Biological effects of acetomycin. II. Inactivation by esterases in vitro.
- 1 January 1987
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 40 (1) , 77-80
- https://doi.org/10.7164/antibiotics.40.77
Abstract
Acetomycin has antitumor activity in vitro but not in vivo. HCT-8 human colon adenocarcinoma assays in the presence of a drug metabolizing system (rat liver S9 fraction) demonstrated that liver enzymes inactivated acetomycin. The structure of acetomycin suggested that an esterase could be the key inactivating enzyme. Assays with porcine liver esterase (EC 3.1.1.1) showed that this enzyme rapidly abolishes the activity of acetomycin against HCT-8 cells. The potential utility of acetomycin as an antitumor agent thus depends on finding a means of preventing esterase inactivation.This publication has 4 references indexed in Scilit:
- Biological effects of acetomycin. I. Activity against tumor cells in vitro and in vivo.The Journal of Antibiotics, 1987
- Enzymic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance.The Journal of Antibiotics, 1984
- Prophage lambda induction of Escherichia coli K12 envA uvrB: a highly sensitive test for potential carcinogens.Proceedings of the National Academy of Sciences, 1976
- Stoffwechselprodukte von Actinomyceten. 12. Mitteilung. Über die Isolierung und Charakterisierung von AcetomycinHelvetica Chimica Acta, 1958